An Inherently Bifunctional Subset of Foxp3 + T Helper Cells Is Controlled by the Transcription Factor Eos

MadhavD Sharma, Lei Huang, Jeong Hyeon Choi, Eun Joon Lee, JamesM Wilson, Henrique Lemos, Fan Pan, BruceR Blazar, DrewM Pardoll, AndrewL Mellor, Huidong Shi, DavidH Munn

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

At sites of inflammation, certain regulatory Tcells (Treg cells) can undergo rapid reprogramming into helper-like cells without loss of the transcription factor Foxp3. We show that reprogramming is controlled by downregulation of the transcription factor Eos (Ikzf4), an obligate corepressor for Foxp3. Reprogramming was restricted to a specific subset of "Eos-labile" Treg cells that was present in the thymus and identifiable by characteristic surface markers and DNA methylation. Mice made deficient in this subset became impaired in their ability to provide help for presentation of new antigens to naive Tcells. Downregulation of Eos required the proinflammatory cytokine interleukin-6 (IL-6), and mice lacking IL-6 had impaired development and function of the Eos-labile subset. Conversely, the immunoregulatory enzyme IDO blocked loss of Eosand prevented the Eos-labile Treg cells from reprogramming. Thus, the Foxp3 + lineage contains acommitted subset of Treg cells capable of rapid conversion into biologically important helper cells. •A subset of Treg cells shows labile expression of the corepressor Eos•These Treg cells can reprogram into helper cells without losing Foxp3•Eos-labile Treg cells are constitutively present in thymus, lymph nodes, and spleen•Reprogrammed Treg cells can help support priming of effector Tcells to new antigen.

Original languageEnglish (US)
Pages (from-to)998-1012
Number of pages15
JournalImmunity
Volume38
Issue number5
DOIs
StatePublished - May 23 2013

Fingerprint

Regulatory T-Lymphocytes
Helper-Inducer T-Lymphocytes
Transcription Factors
Co-Repressor Proteins
Thymus Gland
Down-Regulation
Antigen Presentation
DNA Methylation
Interleukin-6
Lymph Nodes
Cytokines
Inflammation
Antigens

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Cite this

An Inherently Bifunctional Subset of Foxp3 + T Helper Cells Is Controlled by the Transcription Factor Eos . / Sharma, MadhavD; Huang, Lei; Choi, Jeong Hyeon; Lee, Eun Joon; Wilson, JamesM; Lemos, Henrique; Pan, Fan; Blazar, BruceR; Pardoll, DrewM; Mellor, AndrewL; Shi, Huidong; Munn, DavidH.

In: Immunity, Vol. 38, No. 5, 23.05.2013, p. 998-1012.

Research output: Contribution to journalArticle

Sharma, MadhavD ; Huang, Lei ; Choi, Jeong Hyeon ; Lee, Eun Joon ; Wilson, JamesM ; Lemos, Henrique ; Pan, Fan ; Blazar, BruceR ; Pardoll, DrewM ; Mellor, AndrewL ; Shi, Huidong ; Munn, DavidH. / An Inherently Bifunctional Subset of Foxp3 + T Helper Cells Is Controlled by the Transcription Factor Eos In: Immunity. 2013 ; Vol. 38, No. 5. pp. 998-1012.
@article{3e15995dabc846ee977df28451177a09,
title = "An Inherently Bifunctional Subset of Foxp3 + T Helper Cells Is Controlled by the Transcription Factor Eos",
abstract = "At sites of inflammation, certain regulatory Tcells (Treg cells) can undergo rapid reprogramming into helper-like cells without loss of the transcription factor Foxp3. We show that reprogramming is controlled by downregulation of the transcription factor Eos (Ikzf4), an obligate corepressor for Foxp3. Reprogramming was restricted to a specific subset of {"}Eos-labile{"} Treg cells that was present in the thymus and identifiable by characteristic surface markers and DNA methylation. Mice made deficient in this subset became impaired in their ability to provide help for presentation of new antigens to naive Tcells. Downregulation of Eos required the proinflammatory cytokine interleukin-6 (IL-6), and mice lacking IL-6 had impaired development and function of the Eos-labile subset. Conversely, the immunoregulatory enzyme IDO blocked loss of Eosand prevented the Eos-labile Treg cells from reprogramming. Thus, the Foxp3 + lineage contains acommitted subset of Treg cells capable of rapid conversion into biologically important helper cells. •A subset of Treg cells shows labile expression of the corepressor Eos•These Treg cells can reprogram into helper cells without losing Foxp3•Eos-labile Treg cells are constitutively present in thymus, lymph nodes, and spleen•Reprogrammed Treg cells can help support priming of effector Tcells to new antigen.",
author = "MadhavD Sharma and Lei Huang and Choi, {Jeong Hyeon} and Lee, {Eun Joon} and JamesM Wilson and Henrique Lemos and Fan Pan and BruceR Blazar and DrewM Pardoll and AndrewL Mellor and Huidong Shi and DavidH Munn",
year = "2013",
month = "5",
day = "23",
doi = "10.1016/j.immuni.2013.01.013",
language = "English (US)",
volume = "38",
pages = "998--1012",
journal = "Immunity",
issn = "1074-7613",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - An Inherently Bifunctional Subset of Foxp3 + T Helper Cells Is Controlled by the Transcription Factor Eos

AU - Sharma, MadhavD

AU - Huang, Lei

AU - Choi, Jeong Hyeon

AU - Lee, Eun Joon

AU - Wilson, JamesM

AU - Lemos, Henrique

AU - Pan, Fan

AU - Blazar, BruceR

AU - Pardoll, DrewM

AU - Mellor, AndrewL

AU - Shi, Huidong

AU - Munn, DavidH

PY - 2013/5/23

Y1 - 2013/5/23

N2 - At sites of inflammation, certain regulatory Tcells (Treg cells) can undergo rapid reprogramming into helper-like cells without loss of the transcription factor Foxp3. We show that reprogramming is controlled by downregulation of the transcription factor Eos (Ikzf4), an obligate corepressor for Foxp3. Reprogramming was restricted to a specific subset of "Eos-labile" Treg cells that was present in the thymus and identifiable by characteristic surface markers and DNA methylation. Mice made deficient in this subset became impaired in their ability to provide help for presentation of new antigens to naive Tcells. Downregulation of Eos required the proinflammatory cytokine interleukin-6 (IL-6), and mice lacking IL-6 had impaired development and function of the Eos-labile subset. Conversely, the immunoregulatory enzyme IDO blocked loss of Eosand prevented the Eos-labile Treg cells from reprogramming. Thus, the Foxp3 + lineage contains acommitted subset of Treg cells capable of rapid conversion into biologically important helper cells. •A subset of Treg cells shows labile expression of the corepressor Eos•These Treg cells can reprogram into helper cells without losing Foxp3•Eos-labile Treg cells are constitutively present in thymus, lymph nodes, and spleen•Reprogrammed Treg cells can help support priming of effector Tcells to new antigen.

AB - At sites of inflammation, certain regulatory Tcells (Treg cells) can undergo rapid reprogramming into helper-like cells without loss of the transcription factor Foxp3. We show that reprogramming is controlled by downregulation of the transcription factor Eos (Ikzf4), an obligate corepressor for Foxp3. Reprogramming was restricted to a specific subset of "Eos-labile" Treg cells that was present in the thymus and identifiable by characteristic surface markers and DNA methylation. Mice made deficient in this subset became impaired in their ability to provide help for presentation of new antigens to naive Tcells. Downregulation of Eos required the proinflammatory cytokine interleukin-6 (IL-6), and mice lacking IL-6 had impaired development and function of the Eos-labile subset. Conversely, the immunoregulatory enzyme IDO blocked loss of Eosand prevented the Eos-labile Treg cells from reprogramming. Thus, the Foxp3 + lineage contains acommitted subset of Treg cells capable of rapid conversion into biologically important helper cells. •A subset of Treg cells shows labile expression of the corepressor Eos•These Treg cells can reprogram into helper cells without losing Foxp3•Eos-labile Treg cells are constitutively present in thymus, lymph nodes, and spleen•Reprogrammed Treg cells can help support priming of effector Tcells to new antigen.

UR - http://www.scopus.com/inward/record.url?scp=84878169329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878169329&partnerID=8YFLogxK

U2 - 10.1016/j.immuni.2013.01.013

DO - 10.1016/j.immuni.2013.01.013

M3 - Article

VL - 38

SP - 998

EP - 1012

JO - Immunity

JF - Immunity

SN - 1074-7613

IS - 5

ER -